Mina Kim
2019
In 2019, Mina Kim earned a total compensation of $2.3M as Former SVP, Corporate Strategy and General Counsel at Atara Biotherapeutics, a 31% decrease compared to previous year.
Compensation breakdown
| Option Awards | $909,080 |
|---|---|
| Salary | $364,494 |
| Stock Awards | $1,034,714 |
| Other | $20,546 |
| Total | $2,328,833 |
Kim received $1M in stock awards, accounting for 44% of the total pay in 2019.
Kim also received $909.1K in option awards, $364.5K in salary and $20.5K in other compensation.
Rankings
In 2019, Mina Kim's compensation ranked 5,180th out of 13,971 executives tracked by ExecPay. In other words, Kim earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,180 out of 13,971 | 63rd |
Division Manufacturing | 1,927 out of 5,695 | 66th |
Major group Chemicals And Allied Products | 677 out of 2,194 | 69th |
Industry group Drugs | 568 out of 1,880 | 70th |
Industry Biological Products, Except Diagnostic Substances | 128 out of 389 | 67th |
Source: SEC filing on April 22, 2020.
Kim's colleagues
We found five more compensation records of executives who worked with Mina Kim at Atara Biotherapeutics in 2019.
2019
Isaac Ciechanover
Atara Biotherapeutics
Chief Executive Officer
2019
Pascal Touchon
Atara Biotherapeutics
Chief Executive Officer
2019
Dietmar Berger
Atara Biotherapeutics
Former Global Head of Research & Development
2019
Joseph Newell
Atara Biotherapeutics
EVP, Chief Technical Operations Officer
2019
Utpal Koppikar
Atara Biotherapeutics